Open AccessZoledronic AcidVersusAlendronate for the Prevention of Bone Loss after Heart or Liver Transplantation
Author(s) -
Elizabeth Shane,
Adi Cohen,
Emily M. Stein,
Donald J. McMahon,
Chiyuan Zhang,
Polly Young,
Kavita Pandit,
Ronald B. Staron,
Elizabeth C. Verna,
Robert Brown,
Susan Restaino,
Donna Mancini
Publication year - 2012
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2012-2804
Subject(s) - zoledronic acid , medicine , liver transplantation , bone density conservation agents , transplantation , diphosphonates , osteoporosis , bone density , bone resorption
The first year after transplantation is characterized by rapid bone loss.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom